Nancy Schoenbrunner

Nancy Schoenbrunner is a seasoned executive in the diagnostics industry, currently serving as the Chief Executive Officer and Co-Founder of AmplifiDx since August 2020. In addition to this role, Nancy is a Co-Founder and Scientific Advisor at Rosalind Dx since April 2024, and holds the position of Co-Founder and Advisory Chief Product Officer at Anasens, as well as Co-Founder and President at BonaDea Diagnostics. Prior experience includes the role of Chief Executive Officer at Nanogenecs Diagnostics from August 2019 to June 2020, and Head of Diagnostic Development at Scipher Medicine from March 2018 to August 2019. Nancy's significant tenure at Roche from 1998 to 2018 involved numerous leadership roles, including Director of Research for the Molecular Point of Care team. Nancy holds a Ph.D. in Biophysics from the University of Basel, a Diplom in Biochemistry from the University of Bayreuth, and a Bachelor's degree in Biochemistry from Georgetown University, complemented by studies in Molecular Biology, Biochemistry, and Physics at The University of Edinburgh.